Gianluca Campo
Gianluca Campo
U.O. Cardiologia, Azienda Ospedaliera di Ferrara
بريد إلكتروني تم التحقق منه على unife.it
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
M Valgimigli, G Campo, M Monti, P Vranckx, G Percoco, C Tumscitz, ...
Circulation 125 (16), 2015-2026, 2012
6992012
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial
M Valgimigli, G Percoco, P Malagutti, G Campo, F Ferrari, D Barbieri, ...
Jama 293 (17), 2109-2117, 2005
3872005
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year …
PW Serruys, B Chevalier, Y Sotomi, A Cequier, D Carrié, JJ Piek, ...
The Lancet 388 (10059), 2479-2491, 2016
3862016
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: relationship with gene polymorphisms and …
G Campo, G Parrinello, P Ferraresi, B Lunghi, M Tebaldi, M Miccoli, ...
Journal of the American College of Cardiology 57 (25), 2474-2483, 2011
3562011
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the …
M Valgimigli, G Campo, G Percoco, L Bolognese, C Vassanelli, ...
Jama 299 (15), 1788-1799, 2008
3132008
Five-year outcomes with PCI guided by fractional flow reserve
P Xaplanteris, S Fournier, NHJ Pijls, WF Fearon, E Barbato, PAL Tonino, ...
New England Journal of Medicine 379 (3), 250-259, 2018
2662018
Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents
JE Sousa, MA Costa, A Abizaid, F Feres, AC Seixas, LF Tanajura, ...
Circulation 111 (18), 2326-2329, 2005
2602005
CLINICAL PERSPECTIVE
M Valgimigli, G Campo, N De Cesare, E Meliga, P Vranckx, A Furgieri, ...
Circulation 119 (25), 3215-3222, 2009
255*2009
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates
M Valgimigli, A Patialiakas, A Thury, E McFadden, S Colangelo, G Campo, ...
Journal of the American College of Cardiology 65 (8), 805-815, 2015
2062015
Short physical performance battery and all-cause mortality: systematic review and meta-analysis
R Pavasini, J Guralnik, JC Brown, M Di Bari, M Cesari, F Landi, B Vaes, ...
BMC medicine 14 (1), 215, 2016
2052016
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy
O De Filippo, F D’Ascenzo, F Angelini, PP Bocchino, F Conrotto, ...
New England Journal of Medicine, 2020
1872020
Complete revascularization with multivessel PCI for myocardial infarction
SR Mehta, DA Wood, RF Storey, R Mehran, KR Bainey, H Nguyen, ...
New England Journal of Medicine 381 (15), 1411-1421, 2019
1732019
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised …
P Vranckx, M Valgimigli, L Eckardt, J Tijssen, T Lewalter, G Gargiulo, ...
The Lancet 394 (10206), 1335-1343, 2019
1682019
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction …
M Valgimigli, M Tebaldi, G Campo, S Gambetti, L Bristot, M Monti, ...
JACC: Cardiovascular Interventions 5 (3), 268-277, 2012
1642012
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary …
S Garg, G Sarno, PW Serruys, AE Rodriguez, L Bolognese, M Anselmi, ...
JACC: Cardiovascular Interventions 4 (1), 66-75, 2011
1602011
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials
M Valgimigli, G Biondi-Zoccai, M Tebaldi, AWJ van't Hof, G Campo, ...
European heart journal 31 (1), 35-49, 2010
1602010
Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study
G Campo, M Valgimigli, D Gemmati, G Percoco, S Tognazzo, G Cicchitelli, ...
Journal of the American College of Cardiology 48 (11), 2178-2185, 2006
1602006
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury
G Morciano, C Giorgi, M Bonora, S Punzetti, R Pavasini, MR Wieckowski, ...
Journal of molecular and cellular cardiology 78, 142-153, 2015
1592015
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban …
G Campo, L Fileti, N de Cesare, E Meliga, A Furgieri, F Russo, ...
Journal of the American College of Cardiology 56 (18), 1447-1455, 2010
1402010
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a …
M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra, ...
The Lancet 387 (10016), 357-366, 2016
1392016
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20